Literature DB >> 8366086

Nonbiased identification of DNA sequences that bind thyroid hormone receptor alpha 1 with high affinity.

R W Katz1, R J Koenig.   

Abstract

Thyroid hormone receptors are transcription factors that bind to specific DNA sequences and regulate gene expression in a ligand-dependent manner. Although thyroid hormone receptors are known to bind to the hexamer 5'-AGGTCA, it is not known if this represents the optimal binding site. Therefore, a nonbiased strategy was used to identify DNA sequences which bind thyroid hormone receptor alpha 1 with high affinity. Such DNA sequences were isolated from a pool of random sequences using a strategy combining an electrophoretic mobility shift assay with the polymerase chain reaction. It was found that thyroid hormone receptor alpha 1 binds with highest affinity to the octamer 5'-TAAGGTCA. Mutation of the two 5'-nucleotides decreased the affinity of thyroid hormone receptor alpha 1 for this DNA sequence approximately 5-fold, and the importance of those nucleotides in receptor binding was confirmed by DNA footprinting. A single copy of the octamer sequence (but not the hexamer AGGTCA) could impart T3 responsiveness to a heterologous promoter in a transient transfection assay. The results indicate that the optimal binding site for thyroid hormone receptor alpha 1 is 2 base pairs larger than previously thought, and that a single binding site can function as a response element. In addition, we speculate that the optimal binding sites for thyroid hormone, vitamin D, and retinoic acid receptors may not be identical, as had previously been thought.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8366086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors.

Authors:  S Y Cheng
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2005-01-13

3.  Variable RXR requirements for thyroid hormone responsiveness of endogenous genes.

Authors:  Ericka M Diallo; Kenneth G Wilhelm; Deborah L Thompson; Ronald J Koenig
Journal:  Mol Cell Endocrinol       Date:  2006-12-11       Impact factor: 4.102

4.  DNA binding and transcription activation specificity of hepatocyte nuclear factor 4.

Authors:  J D Fraser; V Martinez; R Straney; M R Briggs
Journal:  Nucleic Acids Res       Date:  1998-06-01       Impact factor: 16.971

5.  DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia.

Authors:  H Hauksdóttir; M L Privalsky
Journal:  Cell Growth Differ       Date:  2001-02

6.  Cooperative formation of high-order oligomers by retinoid X receptors: an unexpected mode of DNA recognition.

Authors:  H Chen; M L Privalsky
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

7.  Isolation of a thyroid hormone-responsive gene by immunoprecipitation of thyroid hormone receptor-DNA complexes.

Authors:  J Bigler; R N Eisenman
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs.

Authors:  M E Carter; T Gulick; D D Moore; D P Kelly
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

Review 9.  The actions of thyroid hormone signaling in the nucleus.

Authors:  Kristen R Vella; Anthony N Hollenberg
Journal:  Mol Cell Endocrinol       Date:  2017-03-10       Impact factor: 4.102

10.  Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire.

Authors:  I H Chan; M L Privalsky
Journal:  Oncogene       Date:  2009-09-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.